Manufacturing, Biologic Drugs

Continuous Peptide Manufacturing Process is a New Alternative to Batch Manufacturing

March 26, 2019

A continuous peptide manufacturing process invented by Swedish Biomimetics 3000 Ltd is a platform technology also applicable to other solid-phase chemical processes, such as chromatography.

MaSTherCell Announces New Commercial Manufacturing Facility for Cell and Gene Therapies

March 26, 2019

Belgium-based CDMO MaSTherCell will expand its European manufacturing capacity for cell and gene therapy products by setting up a new facility in Belgium.

The Link Between Manufacturing and Commercialization in Gene and Cell Therapy

March 20, 2019

Equipment and Processing Report

Think ahead to production requirements when planning strategies in early development of gene and cell therapies.

Lonza, Sheba to Collaborate on Automated Cell-Therapy Manufacturing

March 20, 2019

The companies aim to assess automated CAR-T cell therapy manufacturing at the point-of-care and develop technologies to facilitate patient access to immunotherapies.

Alcami Announces Biologics Enterprise

March 20, 2019

Alcami Biologics formed to meet market demands for biological drug development services.

GE Healthcare Announces Digital Collaboration with Amgen

March 12, 2019

The collaboration’s enhanced data exchange combined with advanced analytics are expected to reduce raw material variability and improve biomanufacturing performance reliability.

Fujifilm to Acquire Large-Scale Biologics Manufacturing Site from Biogen in $890-Million Deal

March 12, 2019

The acquisition of the site in Copenhagen, Denmark, will significantly expand Fujifilm’s capacity and capabilities.

Krystal Biotech Opens Gene-Therapy Manufacturing Facility

March 08, 2019

The new facility, located at the company’s headquarters in Pittsburgh, PA, is expected to meet all clinical and commercial development needs of the company’s lead gene therapy program.

Iksuda Therapeutics, Femtogenix Sign License Agreement Targeting Difficult-to-Treat Solid Tumors

March 08, 2019

Iksuda Therapeutics and Femtogenix, have signed a license agreement aimed at progressing Iksuda’s lead ADC to clinic, with the aim of targeting difficult-to-treat solid tumors.

Embracing the Digital Factory for Bio/Pharma Manufacturing

March 02, 2019

New technologies in the digital factory enhance quality, efficiency, and flexibility for bio/pharmaceutical manufacturing.